MyFinsight
Home
Blog
About
Contact
a: the income statement
Download
Download image
Applied Markets
$614M
Agilent Cross Lab
$1,002M
(93.44%↑ Y/Y)
Life Sciences And
Diagnostics Markets
$603M
Applied Markets
$326M
Agilent Cross Lab
$811M
(79.42%↑ Y/Y)
Life Sciences And
Diagnostics Markets
$786M
Applied Markets
$374M
Agilent Cross Lab
$1,095M
(62.46%↑ Y/Y)
Life Sciences And
Diagnostics Markets
$1,337M
Asia Pacific
$2,219M
(2.40%↑ Y/Y)
Europe
$1,923M
(8.64%↑ Y/Y)
Americas
$2,806M
(9.06%↑ Y/Y)
Net revenue
$6,948M
(6.73%↑ Y/Y)
Other income
(expense), net
$6M
(-87.76%↓ Y/Y)
Interest income
$62M
(-22.50%↓ Y/Y)
Income from operations
$1,479M
(-0.60%↓ Y/Y)
Selling, general and
administrative
$1,709M
(8.99%↑ Y/Y)
Research and development
expense
$455M
(-5.01%↓ Y/Y)
Cost of revenue
$3,305M
(11.09%↑ Y/Y)
Income before taxes, as
reported
$1,435M
(-5.65%↓ Y/Y)
Interest expense
$112M
(16.67%↑ Y/Y)
Net income
$1,303M
(1.09%↑ Y/Y)
Provision for income taxes
$132M
(-43.10%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
A_BIG
AGILENT TECHNOLOGIES, INC. (A)
A_BIG
AGILENT TECHNOLOGIES, INC. (A)